These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24259385)

  • 1. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.
    Fletcher NF; Sutaria R; Jo J; Barnes A; Blahova M; Meredith LW; Cosset FL; Curbishley SM; Adams DH; Bertoletti A; McKeating JA
    Hepatology; 2014 Apr; 59(4):1320-30. PubMed ID: 24259385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner.
    Mee CJ; Farquhar MJ; Harris HJ; Hu K; Ramma W; Ahmed A; Maurel P; Bicknell R; Balfe P; McKeating JA
    Gastroenterology; 2010 Mar; 138(3):1134-42. PubMed ID: 19944696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
    Israelow B; Narbus CM; Sourisseau M; Evans MJ
    Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
    Baktash Y; Madhav A; Coller KE; Randall G
    Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway.
    Fletcher NF; Clark AR; Balfe P; McKeating JA
    J Gen Virol; 2017 Mar; 98(3):405-412. PubMed ID: 27983476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
    Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
    J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
    Zhang S; Kodys K; Babcock GJ; Szabo G
    Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SR-BI partner PDZK1 facilitates hepatitis C virus entry.
    Eyre NS; Drummer HE; Beard MR
    PLoS Pathog; 2010 Oct; 6(10):e1001130. PubMed ID: 20949066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
    So CW; Sourisseau M; Sarwar S; Evans MJ; Randall G
    PLoS Pathog; 2023 Dec; 19(12):e1011887. PubMed ID: 38157366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
    Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
    Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
    Ulitzky L; Lafer MM; KuKuruga MA; Silberstein E; Cehan N; Taylor DR
    PLoS One; 2016; 11(1):e0145212. PubMed ID: 26731262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration.
    Wilson GK; Brimacombe CL; Rowe IA; Reynolds GM; Fletcher NF; Stamataki Z; Bhogal RH; Simões ML; Ashcroft M; Afford SC; Mitry RR; Dhawan A; Mee CJ; Hübscher SG; Balfe P; McKeating JA
    J Hepatol; 2012 Apr; 56(4):803-9. PubMed ID: 22178269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.
    Shrivastava S; Mukherjee A; Ray R; Ray RB
    J Virol; 2013 Nov; 87(22):12284-90. PubMed ID: 24006444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cell polarization on hepatitis C virus entry.
    Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
    J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
    Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
    PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.